How Will Technology Change Health Care? Thomas R. Insel, M.D.
San Diego, CA
2:30pm - 4:00pm
Attendance is open to public
Register via Eventbrite for free or contact Francisco Lio at email@example.com
Traveling south or north bound on I-5, take exit 29 for Genesee Ave
If coming from the north, keep right at fork and follow signs for Genesee Ave West If coming from the south, upon exiting turn left onto Genesee Ave
After 0.7 miles continue straight onto N. Torrey Pines Road
After 0.8 miles take the Callan Road exit (right)
Merge onto Callan Road
Turn right onto Torreyana Rd
The parking garage entrance will be on your right
About the event:
Dr. Insel will talk about leading edge technologies that may one day be of impact to the care of patients suffering from psychiatric conditions. He will discuss the advent of digital phenotyping, modern cognitive and linguistic assessments, and powerful computational approaches applied to complex data which now permit a deeper analysis of behavior than would have been possible even five years ago. Will this phenomic analysis in psychiatry serve the same role as molecular profiling in oncology? Will subgroups selected by modern phenomics be predictive of treatment response or clinical course? This presentation will argue that a detailed analysis of behavior and cognition combined with functional connectomics can become a pathway to precision medicine for psychiatry.
About Dr. Insel:
Thomas R. lnsel, M.D., a neuroscientist and psychiatrist, leads the Mental Health Team at Verily (formerly Google Life Sciences) in South San Francisco, CA. From 2002-2015, Dr. Insel served as Director of the National Institute of Mental Health (NIMH). In that role he also served as Chair of the Interagency Autism Coordinating Committee (IACC) as well as co-lead of the NIH BRAIN Initiative. Prior to serving as NIMH Director, Dr. lnsel was Professor of Psychiatry at Emory University where he was founding director of the Center for Behavioral Neuroscience and director of the Yerkes Regional Primate Center in Atlanta. Dr. Insel’s research has examined the neural basis of complex social behaviors, including maternal care and attachment. A member of the National Academy of Medicine, he has received numerous national and international awards and served in several leadership roles at NIH.
Don’t miss the networking event outside the Illumina Theater right after the presentation. Drinks and appetizers are sponsored by Neuropore Therapies, Inc.
Neuropore Therapies, Inc. is a San Diego, California based biopharmaceutical company that is focused on the discovery and development of novel small molecule therapeutics for the treatment Parkinson’s disease and other neurodegenerative disorders. The approaches being taken by Neuropore Therapies target the core pathological processes underlying these disorders including the intracellular accumulation of neurotoxic misfolded proteins and the associated neuroinflammation. As such, the therapeutics being developed by Neuropore may provide the first effective means for slowing the unremitting progression of these devastating diseases.
Contact: Francisco Lio
Contact Phone: 8587684105
Contact Email: firstname.lastname@example.org
Illumina Theater, Alexandria at Torrey Pines
10996 North Torrey Pines Road
San Diego, CA 92121